T cell cross-reactivity in autoimmune-like hepatitis triggered by COVID-19

The study, titled “T cell cross-reactivity in autoimmune-like hepatitis triggered by COVID-19” presents a significant finding in understanding how COVID-19 may trigger autoimmune responses, specifically autoimmune-like hepatitis. Here’s a detailed summary: Overview: Key Elements: Conclusion: Read More: https://www.sciencedirect.com/science/article/pii/S2949928323000093